ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,638,904 | +6.9% | 214,275 | +38.3% | 0.01% | +11.1% |
| Q2 2023 | $7,148,443 | +80.9% | 154,963 | +57.3% | 0.01% | +50.0% |
| Q1 2023 | $3,950,973 | +43.5% | 98,528 | +65.8% | 0.01% | +50.0% |
| Q4 2022 | $2,753,114 | -99.9% | 59,424 | -10.0% | 0.00% | 0.0% |
| Q3 2022 | $2,732,936,000 | +208.5% | 65,997 | +344.5% | 0.00% | +300.0% |
| Q2 2022 | $885,891,000 | -29.3% | 14,849 | -13.9% | 0.00% | -50.0% |
| Q1 2022 | $1,252,622,000 | -68.2% | 17,249 | -63.2% | 0.00% | -66.7% |
| Q4 2021 | $3,937,094,000 | +331.8% | 46,820 | +363.2% | 0.01% | +500.0% |
| Q3 2021 | $911,731,000 | +28.6% | 10,109 | +35.9% | 0.00% | 0.0% |
| Q2 2021 | $709,023,000 | -83.8% | 7,436 | -80.7% | 0.00% | -83.3% |
| Q1 2021 | $4,389,189,000 | +75.3% | 38,549 | +113.1% | 0.01% | +20.0% |
| Q4 2020 | $2,503,922,000 | -12.2% | 18,088 | -47.9% | 0.01% | +25.0% |
| Q3 2020 | $2,851,418,000 | +114.3% | 34,693 | +104.0% | 0.00% | +100.0% |
| Q2 2020 | $1,330,366,000 | -24.8% | 17,008 | -57.3% | 0.00% | -50.0% |
| Q1 2020 | $1,769,736,000 | +92.3% | 39,832 | +84.9% | 0.00% | +100.0% |
| Q4 2019 | $920,230,000 | +3.6% | 21,546 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $888,027,000 | -19.6% | 20,758 | +19.4% | 0.00% | 0.0% |
| Q2 2019 | $1,104,392,000 | -37.1% | 17,392 | -31.2% | 0.00% | -50.0% |
| Q1 2019 | $1,754,461,000 | +232.5% | 25,295 | +108.4% | 0.00% | +300.0% |
| Q4 2018 | $527,717,000 | -40.4% | 12,137 | +4.6% | 0.00% | 0.0% |
| Q3 2018 | $885,773,000 | -25.6% | 11,603 | -25.1% | 0.00% | -50.0% |
| Q2 2018 | $1,191,101,000 | -3.4% | 15,495 | -35.9% | 0.00% | 0.0% |
| Q1 2018 | $1,233,346,000 | +24.6% | 24,188 | +13.4% | 0.00% | 0.0% |
| Q4 2017 | $989,564,000 | +27.3% | 21,336 | +46.1% | 0.00% | 0.0% |
| Q3 2017 | $777,596,000 | -14.9% | 14,600 | -0.7% | 0.00% | -33.3% |
| Q2 2017 | $913,576,000 | +54.5% | 14,709 | +68.6% | 0.00% | +50.0% |
| Q1 2017 | $591,313,000 | -8.4% | 8,724 | -5.0% | 0.00% | -33.3% |
| Q4 2016 | $645,446,000 | +203.9% | 9,180 | +206.6% | 0.00% | +200.0% |
| Q3 2016 | $212,394,000 | -47.5% | 2,994 | -63.8% | 0.00% | -50.0% |
| Q2 2016 | $404,926,000 | +21954.8% | 8,279 | +28448.3% | 0.00% | – |
| Q1 2016 | $1,836,000 | -99.8% | 29 | -99.6% | 0.00% | -100.0% |
| Q4 2015 | $879,042,000 | +16.1% | 7,836 | -0.3% | 0.00% | 0.0% |
| Q3 2015 | $757,093,000 | +147.5% | 7,861 | +163.2% | 0.00% | +100.0% |
| Q2 2015 | $305,839,000 | +2591.8% | 2,987 | +1532.2% | 0.00% | – |
| Q1 2015 | $11,362,000 | -50.1% | 183 | -54.5% | 0.00% | – |
| Q3 2014 | $22,753,000 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |